Energy sources identify metabolic phenotypes in pancreatic cancer. (Q38959840)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

review article

1 reference

title

Energy sources identify metabolic phenotypes in pancreatic cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Guopei Luo

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Xianjun Yu

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

11

Liang Liu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

8

Jinfeng Xiang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

9

Dingkong Liang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

author name string

Chen Liang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Yi Qin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Bo Zhang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Shunrong Ji

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Wenyan Xu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Jiang Liu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Qiangsheng Hu

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Chen Liu

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Quanxing Ni

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Jin Xu

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

publication date

20 September 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

Acta Biochimica et Biophysica Sinica

23 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

page(s)

969-979

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

Metabolic reprogramming: a cancer hallmark even warburg did not anticipate

23 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

On the Origin of Cancer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

THE METABOLISM OF TUMORS IN THE BODY

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Loss of stromal caveolin-1 leads to oxidative stress, mimics hypoxia and drives inflammation in the tumor microenvironment, conferring the "reverse Warburg effect": a transcriptional informatics analysis with validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Glutamine addiction: a new therapeutic target in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Lipogenesis and lipolysis: the pathways exploited by the cancer cells to acquire fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Metabolic reprogramming: the emerging concept and associated therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Genetics and biology of pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Cancer statistics, 2016

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Biology and management of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Metabolic phenotypes in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Metabolism addiction in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Cancer cell metabolism: Warburg and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Changing the way we do business: recommendations to accelerate biomarker development in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Stromal biology and therapy in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Pancreatic tumor cell metabolism: focus on glycolysis and its connected metabolic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Evolutionary dynamics of carcinogenesis and why targeted therapy does not work.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

The patterns and dynamics of genomic instability in metastatic pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

MCT4 defines a glycolytic subtype of pancreatic cancer with poor prognosis and unique metabolic dependencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

SSBP1 Suppresses TGFβ-Driven Epithelial-to-Mesenchymal Transition and Metastasis in Triple-Negative Breast Cancer by Regulating Mitochondrial Retrograde Signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

FBW7 (F-box and WD Repeat Domain-Containing 7) Negatively Regulates Glucose Metabolism by Targeting the c-Myc/TXNIP (Thioredoxin-Binding Protein) Axis in Pancreatic Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Cannabinoids inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

The biology of cancer: metabolic reprogramming fuels cell growth and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Disrupting proton dynamics and energy metabolism for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Glycolysis, tumor metabolism, cancer growth and dissemination. A new pH-based etiopathogenic perspective and therapeutic approach to an old cancer question

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

ALDOA functions as an oncogene in the highly metastatic pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Energy metabolism in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Cancer metabolism: facts, fantasy, and fiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Understanding the "lethal" drivers of tumor-stroma co-evolution: emerging role(s) for hypoxia, oxidative stress and autophagy/mitophagy in the tumor micro-environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Waves of gene regulation suppress and then restore oxidative phosphorylation in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

PGC1α expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

MYC/PGC-1α Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Epithelial and mesenchymal tumor compartments exhibit in vivo complementary patterns of vascular perfusion and glucose metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Glutamine and cancer: cell biology, physiology, and clinical opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Understanding the Warburg effect: the metabolic requirements of cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Pancreatic Cancer Metabolism: Breaking It Down to Build It Back Up

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Proteomic analysis reveals Warburg effect and anomalous metabolism of glutamine in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

A role for ATP-citrate lyase, malic enzyme, and pyruvate/citrate cycling in glucose-induced insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Mitochondrial Phosphoenolpyruvate Carboxykinase Regulates Metabolic Adaptation and Enables Glucose-Independent Tumor Growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Inflammation and mitochondrial fatty acid beta-oxidation link obesity to early tumor promotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Increased lipid metabolism and cell turnover of MiaPaCa2 cells induced by high-fat diet in an orthotopic system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Role of abnormal lipid metabolism in development, progression, diagnosis and therapy of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Alteration of strain background and a high omega-6 fat diet induces earlier onset of pancreatic neoplasia in EL-Kras transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Integration of metabolomics and transcriptomics revealed a fatty acid network exerting growth inhibitory effects in human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Trans-10, cis-12 conjugated linoleic acid induced cell death in human colon cancer cells through reactive oxygen species-mediated ER stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

The metabolic features of normal pancreas and pancreatic adenocarcinoma: preliminary result of in vivo proton magnetic resonance spectroscopy at 3.0 T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Metabolomic and transcriptomic profiling of human K-ras oncogene transgenic rats with pancreatic ductal adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

The complex landscape of pancreatic cancer metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Peroxisomal branched chain fatty acid beta-oxidation pathway is upregulated in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Fine-tuning the lipogenic/lipolytic balance to optimize the metabolic requirements of cancer cell growth: molecular mechanisms and therapeutic perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

PET/CT of cancer patients: part 1, pancreatic neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative ¹⁸F-FDG PET/CT in Patients with Pancreatic Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

FDG-PET in diagnosis, staging and prognosis of pancreatic carcinoma: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Cancer-associated stroma affects FDG uptake in experimental carcinomas. Implications for FDG-PET delineation of radiotherapy target

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Non-invasive vascular imaging: assessing tumour vascularity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Dependence of FDG uptake on tumor microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Gene expression profiling in cervical cancer: an exploration of intratumor heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Intratumoral Heterogeneous F-18 Fluorodeoxyglucose Uptake Corresponds with Glucose Transporter-1 and Ki-67 Expression in a Case of Krukenberg Tumor: Localization of Intratumoral Hypermetabolic Focus by Fused PET/MR Image

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Intratumoral heterogeneity of (18)F-FDG uptake predicts survival in patients with pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Correlation of intra-tumour heterogeneity on 18F-FDG PET with pathologic features in non-small cell lung cancer: a feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Diagnosis of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) --usefulness and limitations in "clinical reality".

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Circulating Metabolites and Survival Among Patients With Pancreatic Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Targeting cellular metabolism to improve cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Targeting mitochondrial glutaminase activity inhibits oncogenic transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

A new mechanism of drug resistance in breast cancer cells: fatty acid synthase overexpression-mediated palmitate overproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Glycolysis inhibition for anticancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Emerging metabolic targets in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Control of gluconeogenesis by metformin: does redox trump energy charge?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Novel mechanism of inhibition of rat kidney-type glutaminase by bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Fatty acid synthase as a potential therapeutic target in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

FGFR3 stimulates stearoyl CoA desaturase 1 activity to promote bladder tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Principles and current strategies for targeting autophagy for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Overcoming immunosuppression as a new immunotherapeutic approach against pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Modulation of oxidative stress as an anticancer strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Exploiting the bad eating habits of Ras-driven cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Optimizing cancer radiotherapy with 2-deoxy-d-glucose dose escalation studies in patients with glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Hypoxia, HIF1 and glucose metabolism in the solid tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

Cancer as a metabolic disease: implications for novel therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Identifiers

DOI

10.1093/ABBS/GMW097

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

1 reference